Personalized medication for overactive bladder with imidafenacin treatment
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
Price : $35 *
At a glance
- Drugs Imidafenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms PERMIT study
- 05 Feb 2019 Status changed from recruiting to discontinued.
- 05 Jan 2018 Status changed from not yet recruiting to recruiting.
- 16 Mar 2017 New trial record